• Tidak ada hasil yang ditemukan

links.lww.com/MPG/B799

N/A
N/A
Protected

Academic year: 2024

Membagikan "links.lww.com/MPG/B799"

Copied!
7
0
0

Teks penuh

(1)
(2)
(3)

Table, Supplemental Digital Content 2.

Proposed criteria of pediatric ACLF (PACLF):

PACLF criteria is met by the presence of at least one of the following extra-hepatic organ failures in a child hospitalized with decompensated cirrhosis.

Respiratory Failure Need for mechanical ventilation Circulatory Failure Need for vasoactive medications Renal Failure Need for renal replacement therapy Neurologic Failure Grade III/IV hepatic encephalopathy

Table, Supplemental Digital Content 2. Proposed pediatric acute-on-chronic liver failure (PACLF) criteria.

(4)

decompensated cirrhosis.

All (n=66)

No PACLF (n=46)

PACLF (n=20)

Biliary Atresia* 43 (65%) 32 (70%) 11 (55%)

Genetic causes of cholestasis (PFIC, Alagille#) 4 (6%) 1 (2%) 3 (15%)

Autoimmune Hepatitis (AIH) 1 (2%) 0 (0%) 1 (5%)

Biliary Cirrhosis 3 (5%) 2 (4%) 1 (5%)

Primary Sclerosing Cholangitis (PSC) 3 (5%) 2 (4%) 1 (5%)

PSC/AIH Overlap Syndrome 3 (5%) 3 (7%) 0 (0%)

Alpha 1 Anti-trypsin Deficiency 2 (3%) 2 (4%) 0 (0%)

Cryptogenic Cirrhosis 6 (9%) 3 (7%) 3 (15%)

Congenital Hepatic Fibrosis 1 (2%) 1 (2%) 0 (0%)

 *A total of 4 patients had syndromic biliary atresia with situs inversus, polysplenia. Two patients had dextrocardia with no other cardiac anomalies, one patient had levocardia with interrupted IVC with azygous continuation, and one patient had complex cardiac disease including coarctation of aorta repaired pre-transplant and VSD, fibrous subaortic stenosis both repaired post-transplant.

#A total of 2 patients with Alagille syndrome were included. Both patients had a diagnosis of mild pulmonary artery stenosis with normal cardiac function.

Table, Supplemental Digital Content 3. Underlying diagnosis of all patients hospitalized for decompensated cirrhosis

Footnote: Pediatric Acute-on-chronic liver failure (PACLF)

(5)

Table, Supplemental Digital Content 4.

Characteristics of Organ Failures in PACLF Hospitalizations.

PACLF during Hospitalization (n=23)

PACLF on Admission (n=9)

Number of organ failures

1 organ failure 10 (43%) 6 (67%)

2 organ failures 7 (30%) 2 (22%)

3 organ failures 3 (13%) 1 (11%)

4 organ failures 3 (13%) 0

Type of organ failure

Respiratory Failure 17 (74%) 4 (44%)

Cardiovascular Failure 12 (52%) 6 (67%)

Renal Failure 7 (30%) 0 (0%)

Hepatic Encephalopathy 9 (39%) 3 (33%)

Pediatric acute-on-chronic liver failure (PACLF).

Table, Supplemental Digital Content 4. Characteristics of organ failures during PACLF hospitalizations.

Footnote: Pediatric Acute-on-chronic liver failure (PACLF)

(6)

All (n=186) No PACLF (n=163)

PACLF (n=23) p-value*

Sodium 130.2 ± 6.1 130.3 ± 0.7 126.3 ± 1.2 0.001

Creatinine 0.43 ± 0.52 0.38 ± 0.06 0.94 ± 0.09 <0.001 White Blood Cell

Count

15.3 ± 10.0 13.9 ± 1.0 27.6 ± 1.7 <0.001

Hemoglobin 8.7 ± 1.9 8.8 ± 0.2 7.1 ± 0.4 <0.001

Platelet Count 136.0 ± 103.5 143.3 ± 10.8 47.2 ± 20.1 <0.001

Albumin 2.2 ± 0.6 2.2 ± 0.1 2.0 ± 0.1 NS

Total Bilirubin 12.2 ± 12.1 12.7 ± 1.5 23.0 ± 2.2 <0.001

ALT 188.0 ± 414.2 141.0 ± 35.5 542.0 ± 82.6 <0.001

AST 389.1 ± 1281.5 228.5 ± 102.2 1493.7 ± 253.8 <0.001

GGT 345.5 ± 405.8 340.8 ± 45.7 229.6 ± 86.8 NS

INR 1.8 ± 1.0 1.8 ± 0.1 2.9 ± 0.2 <0.001

Ammonia 114.5 ± 81.8 104.2 ± 16.2 133.7 ± 18.3 NS

Linear mixed models performed for multiple hospitalizations per patient. Least square means ± standard error (SE) are reported.

Alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), International Normalized Ratio (INR), Pediatric acute-on-chronic liver failure (PACLF). Not significant (NS).

* Comparison between PACLF vs. No PACLF.

Table, Supplemental Digital Content 5. Peak laboratory values during hospitalization.

Footnote: Linear mixed models performed for multiple hospitalizations per patient. Least square means ± standard error (SE) are reported.

Alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl

transferase (GGT), International Normalized Ratio (INR), Pediatric acute-on-chronic liver failure (PACLF). Not significant (NS). * Comparison between PACLF vs. No PACLF.

(7)

Table, Supplemental Digital Content 6. Comparison of medications and procedures performed during PACLF and non-PACLF hospitalizations

Footnote: * Comparison between PACLF vs. Non-ACLF, Pediatric Acute-on-chronic liver failure (PACLF)

Table, Supplemental Digital Content 6. Comparison of medications and procedures performed during PACLF and non-PACLF hospitalizations.

All (n=186)

No PACLF (n=163)

PACLF

(n=23) p-value* Medications

Octreotide 41 (22%) 27 (17%) 14 (61%) <0.0001

Vasoactive medications 11 (6%) 0 (0%) 11 (48%) <0.0001

Antibiotics 147 (80%) 124 (76%) 23 (100%) 0.005

Diuretics 107 (58%) 86 (53%) 21 (91%) <0.001

25% Albumin Infusion 98 (53%) 78 (48%) 20 (87%) <0.001 Packed Red Blood Cells

Transfusion

74 (40%) 55 (34%) 19 (83%) <0.0001

Procedures

Esophagogastroduodenoscopy 43 (23%) 33 (20%) 10 (44%) 0.01

Paracentesis 51 (24%) 33 (18%) 18 (58%) <0.0001

Referensi

Dokumen terkait

Penelitian uji kontrol acak terkontrol prospektif terbaru mengenai ECMO pada kasus ARDS adalah conventional ventilation or ECMO for severe adult respiratory failure Gambar 1

the management of acute kidney injury, choice and preparation for renal replacement therapy, and conservative kidney care in the community, to name but a few.. Evidence shows

Conditions Included in Centers for Disease Control and Prevention Severe Maternal Morbidity Composite Acute Myocardial infarction/aneurysm Acute renal failure Adult respiratory